NanoLogix Inc. ( NNLX ),
an innovative biotechnology company in Northeastern Ohio announces that
UNITAID, based in Geneva, Switzerland and hosted by the World Health
Organization (WHO), on Friday published their Tuberculosis
diagnostics technology and market landscape – 3rd edition.
for NanoLogix Technology Cited In UNITAID Annual Report On TB, Through The World Health Organization investment picks